Advances in the development of therapeutics for cytomegalovirus infections
E Acosta, T Bowlin, J Brooks, L Chiang… - The Journal of …, 2020 - academic.oup.com
The development of therapeutics for cytomegalovirus (CMV) infections, while progressing,
has not matched the pace of new treatments of human immunodeficiency virus (HIV) …
has not matched the pace of new treatments of human immunodeficiency virus (HIV) …
Role of epigenetic modification in interferon treatment of hepatitis B virus infection
Z Yang, B Sun, J Xiang, H Wu, S Kan, M Hao… - Frontiers in …, 2022 - frontiersin.org
Human hepatitis B virus (HBV) is a small, enveloped DNA virus that causes acute and
chronic hepatitis. Chronic hepatitis B (CHB) is associated with hepatocellular carcinoma …
chronic hepatitis. Chronic hepatitis B (CHB) is associated with hepatocellular carcinoma …
The functional and antiviral activity of interferon alpha-inducible IFI6 against hepatitis B virus replication and gene expression
Hepatitis B virus is an enveloped DNA virus, that infects more than three hundred and sixty
million people worldwide and leads to severe chronic liver diseases. Interferon-alpha …
million people worldwide and leads to severe chronic liver diseases. Interferon-alpha …
[PDF][PDF] Type-I-IFN-stimulated gene TRIM5γ inhibits HBV replication by promoting HBx degradation
To understand the molecular mechanisms that mediate the anti-hepatitis B virus (HBV) effect
of interferon (IFN) therapy, we conduct high-throughput bimolecular fluorescence …
of interferon (IFN) therapy, we conduct high-throughput bimolecular fluorescence …
Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study
S Zhu, H Zhang, Y Dong, L Wang, Z Xu, W Liu… - Journal of …, 2018 - Elsevier
Background & Aim Chronic infection with hepatitis B virus (HBV) in children is a serious
health problem worldwide. How to treat children with immune-tolerant chronic hepatitis B …
health problem worldwide. How to treat children with immune-tolerant chronic hepatitis B …
Can G-quadruplex become a promising target in HBV therapy?
Y Teng, M Zhu, Y Chi, L Li, Y Jin - Frontiers in Immunology, 2022 - frontiersin.org
The chronic infection with hepatitis B virus (HBV) is an important health problem that affects
millions of people worldwide. Current therapies for HBV always suffer from a poor response …
millions of people worldwide. Current therapies for HBV always suffer from a poor response …
Interferon response in hepatitis C virus-infected hepatocytes: issues to consider in the era of direct-acting antivirals
When interferons (IFNs) bind to their receptors, they upregulate numerous IFN-stimulated
genes (ISGs) with antiviral and immune regulatory activities. Hepatitis C virus (HCV) is a …
genes (ISGs) with antiviral and immune regulatory activities. Hepatitis C virus (HCV) is a …
Advancing immune and cell-based therapies through imaging
V Ponomarev - Molecular Imaging and Biology, 2017 - Springer
Immunotherapies include various approaches, ranging from stimulating effector
mechanisms to counteracting inhibitory and suppressive mechanisms, and creating a forum …
mechanisms to counteracting inhibitory and suppressive mechanisms, and creating a forum …
Ribavirin and its analogs: Сan you teach an old dog new tricks?
MV Chudinov - Fine Chemical Technologies, 2019 - finechem-mirea.ru
Аннотация Обзор посвящен современному состоянию синтетических и биологических
исследований аналогов рибавирина. Рибавирин–нуклеозидный противовирусный …
исследований аналогов рибавирина. Рибавирин–нуклеозидный противовирусный …
[PDF][PDF] Рибавирин и его аналоги: можно ли старую собаку научить новым фокусам?
МВ Чудинов - Тонкие химические технологии.-2019.-14 (4).-С, 2019 - researchgate.net
Обзор посвящен современному состоянию синтетических и биологических
исследований аналогов рибавирина. Рибавирин–нуклеозидный противовирусный …
исследований аналогов рибавирина. Рибавирин–нуклеозидный противовирусный …